Site icon Vision Science Academy

Thyroid Eye Disease: When Your Eyes Talk about Thyroid Status

Kheyali Mondal, B.Optometry

Oculoplasty Optometrist, Dr. Shroff’s Charity Eye Hospital, New Delhi, India

 

Introduction

Thyroid Eye Disease (TED) is an immune mediated inflammatory disorder, usually abbreviated as TED, also known as Graves’ orbitopathy or Thyroid associated Orbitopathy. It causes expansion of the orbital muscles and fat from oedema and deposition of glycosaminoglycans and collagen.(1)

Sign and symptoms of TED (14)

Epidemiology (2,4,5)

How to rule out TED (1, 4)

Grading the Severity (3)

There are various grading systems available for marking the severity of Thyroid eye disease(TED), but VISA is the most used for the assessment of TED. VISA  stands for Vision, Inflammation, Strabismus & Appearance, which it was developed by Dolman & Rootman in 2006. In this Scoring criteria more than 4 out 10 clinical activity scores indicate an active disease.

Discussion   

Thyroid eye disease is managed by an ophthalmologist and any underlying thyroid problems will be managed by an endocrinologist.

These are some recommendations listed below so that patients know what to expect in terms of care and management:

Refer the patient who develop TED to a speciality clinic with extensive experience of managing TED

Figure 1: VISA (Vision, Inflammation, Strabismus, and Appearance) classification form

 

References:

  1. Dolman P. J. (2012). Evaluating Graves’ orbitopathy. Best practice & research. Clinical endocrinology & metabolism, 26(3), 229–248.
  2. Perros, P., Crombie, A. L., Matthews, J. N., & Kendall-Taylor, P. (1993). Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic. Clinical endocrinology, 38(4), 367–372.
  3. Ahn, E. S., & Subramanian, P. S. (2014). Treatment modalities of thyroid related orbitopathy. Indian journal of ophthalmology, 62(10), 999–1002.
  4. Weiler D. L. (2017). Thyroid eye disease: a review. Clinical & experimental optometry, 100(1), 20–25.
  5. Lim, S. L., Lim, A. K., Mumtaz, M., Hussein, E., Wan Bebakar, W. M., & Khir, A. S. (2008). Prevalence, risk factors, and clinical features of thyroid-associated ophthalmopathy in multiethnic Malaysian patients with Graves’ disease. Thyroid : official journal of the American Thyroid Association, 18(12), 1297–1301.

Picture Courtesy

  1. Figure 1: https://webeye.ophth.uiowa.edu/eyeforum/tutorials/thyroid-eye-disease/i/22-VISA.pdf
  2. Thyroid Eye Disease: An Introductory Tutorial and Overview of .June 17, 2023. https://eyerounds.org/tutorials/thyroid-eye-disease/Thyroid-Eye-Disease.pdf
Exit mobile version